JDOC holdings: all 57 positions
JDOC held 57 positions as of Oct 13, 2026. AbbVie Inc is the largest at 8.72%; the top 10 are 50.8% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | AbbVie Inc | ABBV | 8.72% |
| 2 | Eli Lilly & Co | LLY | 7.95% |
| 3 | UnitedHealth Group Inc | UNH | 5.52% |
| 4 | Merck & Co Inc | MRK | 4.86% |
| 5 | Johnson & Johnson | JNJ | 4.67% |
| 6 | Thermo Fisher Scientific Inc | TMO | 4.59% |
| 7 | Novartis AG Common Stock | NOVN | 4.51% |
| 8 | Astrazeneca PLC Common | AZN | 3.91% |
| 9 | Abbott Laboratories | ABT | 3.05% |
| 10 | Danaher Corp | DHR | 3.03% |
| 11 | Novo Nordisk A/S Common | NOVOB | 2.56% |
| 12 | IQVIA Holdings Inc | IQV | 2.25% |
| 13 | Cencora Inc | COR | 2.22% |
| 14 | Humana Inc | HUM | 2.06% |
| 15 | Argenx SE Common Stock | ARGX | 1.94% |
| 16 | Takeda Pharmaceutical Co | 1.90% | |
| 17 | Biogen Inc | BIIB | 1.89% |
| 18 | Bristol-Myers Squibb Co | BMY | 1.81% |
| 19 | Roche Holding AG Common | ROP | 1.81% |
| 20 | Regeneron Pharmaceuticals Inc | REGN | 1.78% |
| 21 | Edwards Lifesciences Corp | EW | 1.73% |
| 22 | Teva Pharmaceutical Ind Ltd | TEVA | 1.59% |
| 23 | Bayer AG Common Stock | BAYN | 1.49% |
| 24 | Centene Corp | CNC | 1.48% |
| 25 | Hoya Corp Common Stock | 1.42% | |
| 26 | Vertex Pharmaceuticals Inc | VRTX | 1.40% |
| 27 | Cardinal Health Inc | CAH | 1.39% |
| 28 | Sandoz Group AG Common | SDZ | 1.30% |
| 29 | Insmed Inc | INSM | 1.21% |
| 30 | Genmab A/S | GEN | 1.07% |
| 31 | Zoetis Inc | ZTS | 1.07% |
| 32 | Fresenius SE & Co Kgaa | FRE | 0.98% |
| 33 | Charles River Laboratories International Inc | CRL | 0.96% |
| 34 | Alnylam Pharmaceuticals Inc | ALNY | 0.87% |
| 35 | Intuitive Surgical Inc | ISRG | 0.82% |
| 36 | Neurocrine Biosciences Inc | NBIX | 0.81% |
| 37 | Medtronic PLC Common | MDT | 0.64% |
| 38 | Convatec Group PLC | CTEC | 0.62% |
| 39 | Bridgebio Pharma Inc | BBIO | 0.58% |
| 40 | Spyre Therapeutics Inc | SYRE | 0.54% |
| 41 | Boston Scientific Corp | BSX | 0.54% |
| 42 | PTC Therapeutics Inc | PTCT | 0.53% |
| 43 | Dyne Therapeutics Inc | DYN | 0.51% |
| 44 | Sartorius AG Preference | 0.50% | |
| 45 | GSK PLC Common Stock Gbp | GSK | 0.50% |
| 46 | Align Technology Inc | ALGN | 0.43% |
| 47 | Stryker Corp | SYK | 0.41% |
| 48 | LB Pharmaceuticals Inc | LBRX | 0.41% |
| 49 | CG oncology Inc | CGON | 0.39% |
| 50 | Erasca Inc | ERAS | 0.32% |
| 51 | Legend Biotech Corp | LEGN | 0.31% |
| 52 | Disc Medicine Inc | IRON | 0.30% |
| 53 | Argenx SE | ARGX | 0.28% |
| 54 | Arcus Biosciences Inc | RCUS | 0.26% |
| 55 | Apnimed Inc | APMD | 0.25% |
| 56 | Bicara Therapeutics Inc | BCAX | 0.19% |
| 57 | Damora Therapeutics Inc | DMRA | 0.10% |
| Cash and other net assets | 0.77% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of JDOC, data as of Oct 13, 2026. https://etfiq.com/funds/jdoc/holdings/
ETFIQ. (Oct 13, 2026). Holdings of JDOC. Retrieved from https://etfiq.com/funds/jdoc/holdings/
[Holdings of JDOC (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/jdoc/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.